Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 29% ± 9% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 22% ± 8% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 3730.06 | 1445 / 1445 | 100% | 14.91 | 183 / 183 |
thymus | 100% | 4542.60 | 653 / 653 | 100% | 21.75 | 605 / 605 |
uterus | 100% | 3033.71 | 170 / 170 | 100% | 17.89 | 459 / 459 |
intestine | 100% | 4409.11 | 966 / 966 | 100% | 15.49 | 525 / 527 |
prostate | 100% | 4663.08 | 245 / 245 | 100% | 17.45 | 500 / 502 |
adrenal gland | 100% | 4307.80 | 258 / 258 | 100% | 18.22 | 229 / 230 |
bladder | 100% | 3764.29 | 21 / 21 | 99% | 17.21 | 501 / 504 |
brain | 99% | 2960.25 | 2626 / 2642 | 100% | 18.92 | 705 / 705 |
ovary | 100% | 2917.88 | 180 / 180 | 99% | 11.56 | 427 / 430 |
stomach | 100% | 3299.94 | 359 / 359 | 99% | 13.92 | 284 / 286 |
lung | 100% | 2576.66 | 577 / 578 | 99% | 11.83 | 1145 / 1155 |
skin | 100% | 3145.24 | 1809 / 1809 | 99% | 11.36 | 466 / 472 |
liver | 100% | 1729.57 | 226 / 226 | 99% | 8.79 | 400 / 406 |
breast | 100% | 2442.15 | 459 / 459 | 98% | 12.10 | 1101 / 1118 |
pancreas | 98% | 1273.36 | 323 / 328 | 99% | 15.07 | 176 / 178 |
kidney | 100% | 3148.65 | 89 / 89 | 97% | 9.98 | 877 / 901 |
lymph node | 0% | 0 | 0 / 0 | 100% | 17.27 | 29 / 29 |
spleen | 100% | 3880.01 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.08 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 10.25 | 1 / 1 |
adipose | 100% | 2266.62 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2040.55 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 100% | 3191.30 | 859 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 9.46 | 79 / 80 |
muscle | 99% | 1587.53 | 792 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 2060.31 | 909 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0060348 | Biological process | bone development |
GO_0008053 | Biological process | mitochondrial fusion |
GO_0005741 | Cellular component | mitochondrial outer membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MIGA2 |
Protein name | Mitoguardin 2 (Protein FAM73B) |
Synonyms | C9orf54 PSEC0112 FAM73B |
Description | FUNCTION: Regulator of mitochondrial fusion: acts by forming homo- and heterodimers at the mitochondrial outer membrane and facilitating the formation of PLD6/MitoPLD dimers. May act by regulating phospholipid metabolism via PLD6/MitoPLD. . |
Accessions | Q7L4E1 ENST00000450073.1 H7C474 ENST00000414342.1 ENST00000684074.1 [Q7L4E1-1] ENST00000439290.5 [Q7L4E1-2] B0QZG3 ENST00000445183.5 [Q7L4E1-3] ENST00000358369.8 [Q7L4E1-1] |